Cytosorbents
CTSO
#10778
Rank
โ‚ฌ16.93 M
Marketcap
5,37ย โ‚ฌ
Share price
3.09%
Change (1 day)
761.65%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -โ‚ฌ16.03 Million

According to Cytosorbents's latest financial reports the company's current earnings are โ‚ฌ37.21 Million. In 2025 the company made an earning of -โ‚ฌ7.7 Million, an increase over its 2024 earnings that were of -โ‚ฌ20.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ16.03 Million108.37%
2025 -โ‚ฌ7.7 Million-62.16%
2024 -โ‚ฌ20.33 Million-22.49%
2023 -โ‚ฌ26.22 Million-13.52%
2022 -โ‚ฌ30.32 Million34.04%
2021 -โ‚ฌ22.62 Million182.17%
2020 -โ‚ฌ8.02 Million-55.97%
2019 -โ‚ฌ18.21 Million14.17%
2018 -โ‚ฌ15.95 Million95.14%
2017 -โ‚ฌ8.18 Million-22.32%
2016 -โ‚ฌ10.52 Million39.1%
2015 -โ‚ฌ7.57 Million-12.89%
2014 -โ‚ฌ8.69 Million89%
2013 -โ‚ฌ4.6 Million26.65%
2012 -โ‚ฌ3.63 Million-26.02%
2011 -โ‚ฌ4.91 Million-288.45%
2010 โ‚ฌ2.6 M-4.17%
2009 โ‚ฌ2.71 M-287.19%
2008 -โ‚ฌ1.46 Million-47.12%
2007 -โ‚ฌ2.75 Million41.78%
2006 -โ‚ฌ1.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚ฌ3.34 B-20,203.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ0.69 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
โ‚ฌ49.63 M-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA